CXCR3 and cerebral malaria: The genetic deletion of CXCL-10 (CXCL-10-/-) or of its receptor CXCR3 (CXCR3-/-) in experimental cerebral malaria (ECM) studies involving Plasmodium berghei ANKA infections attenuates ECM pathogenesis and mortality.